Search Results 241-250 of 19705 for Receptor
Patients with known EGFR (Epidermal growth factor receptor) tyrosine kinase ... Exploring the Role of B-cell Activating Factor Receptor (BAFFR)-based ...
... receptor-T cell therapy featured image. Biotherapeutics. Science Saturday: Addressing the challenges of chimeric antigen receptor-T cell therapy. Marla ...
Interferon gamma receptor deficiency; Interleukin 12 receptor deficiency; Leukocyte adhesion deficiency (LAD); Mannose-binding lectin (MBL) deficiency; MHC ...
T-cell receptor diversity may be key to treatment of follicular lymphoma, Mayo study finds. Joe Dangor. February 19, 2019.
Chimeric antigen receptor (CAR)-T cell therapy was approved by the Food and Drug Administration to treat two main types of patients with hematologic ...
Copland believe they have identified such a target in the thyroid stimulating hormone receptor (TSHR) which is uniquely found on thyroid cancer cells in the ...
Researchers seek to improve success of chimeric antigen receptor-T cell therapy in non-. Cancer. Researchers seek to improve success of chimeric antigen ...
These cancers are referred to as estrogen receptor positive (ER positive) or progesterone receptor positive (PR positive). Hormone therapy for breast cancer ...
A member of the nuclear medicine therapy team talks with a woman before she begins intravenous peptide receptor radionuclide therapy (PRRT). This type of ...
Our research team previously showed that death receptors, which must be present on the cell surface in order for this pathway to be activated, are inhibited ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.